Psychemedics announced the launch of its new ketamine hair testing solution. This innovative testing method marks a significant advancement in the detection and prevention for a drug-free workplace and community. With the introduction of this new testing service, Psychemedics aims to equip organizations with the tools needed to identify and address ketamine use effectively. Key Features and Benefits of Ketamine Hair Testing: Long Detection Window: Unlike traditional drug testing methods, hair analysis can detect ketamine use for up to 90 days, providing a comprehensive overview of an individual’s drug use history. Non-Invasive and Convenient: The hair collection process is simple and noninvasive and can be performed without the need for specialized facilities, making it ideal for various testing environments. High Sensitivity and Specificity: Utilizing advanced technology, Psychemedics’ ketamine hair test ensures highly accurate results, minimizing the risk of false positives and negatives. Comprehensive Drug Panel: This new service can be integrated into existing multi-drug panels offered by Psychemedics, allowing for a broad-spectrum approach to drug testing Support for Various Industries: The ketamine hair test is designed to meet the needs of diverse sectors, including workplace safety programs, educational institutions, rehabilitation centers, law enforcement agencies, and many others.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PMD:
- Psychemedics Corporation Launches New Ketamine Hair Testing Service
- Psychemedics Corporation Reports Second Quarter 2024 Financial Results
- Psychemedics board approves plan to terminate registration of common stock
- Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock